Sensitivity and resolution improvement for in vivo magnetic resonance current-density imaging of the human brain

link to paper

Sensitivity and resolution improvement for in vivo magnetic resonance current-density imaging of the human brain

Cihan Göksu, Klaus Scheffler, Fróði Gregersen, Hasan H. Eroğlu, Rahel Heule, Hartwig R. Siebner, Lars G. Hanson, Axel Thielscher

Abstract

Purpose

Magnetic resonance current-density imaging (MRCDI) combines MRI with low-intensity transcranial electrical stimulation (TES; 1-2 mA) to map current flow in the brain. However, usage of MRCDI is still hampered by low measurement sensitivity and image quality.

Methods

Recently, a multigradient-echo–based MRCDI approach has been introduced that presently has the best-documented efficiency. This MRCDI approach has now been advanced in three directions and has been validated by phantom and in vivo experiments. First, the importance of optimum spoiling for brain imaging was verified. Second, the sensitivity and spatial resolution were improved by using acquisition weighting. Third, navigators were added as a quality control measure for tracking physiological noise. Combining these advancements, the optimized MRCDI method was tested by using 1 mA TES for two different injection profiles.

Results

For a session duration of 4:20 min, the new MRCDI method was able to detect TES-induced magnetic fields at a sensitivity level of 84 picotesla, representing a twofold efficiency increase against our original method. A comparison between measurements and simulations based on personalized head models showed a consistent increase in the coefficient of determination of ΔR 2 = 0.12 for the current-induced magnetic fields and ΔR 2 = 0.22 for the current flow reconstructions. Interestingly, some of the simulations still clearly deviated from the measurements despite the strongly improved measurement quality. This highlights the utility of MRCDI to improve head models for TES simulations.

Conclusion

The achieved sensitivity improvement is an important step from proof-of-concept studies toward a broader application of MRCDI in clinical and basic neuroscience research.